Javier, Esterlita L.

HRN: 03-08-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/27/2023
10/04/2023
IVT
600 Mg
Q8hrs
ABSCESS
Checking Final Appropriateness 
09/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/27/2023
10/04/2023
IVT
1.5grams
Q6hrs
ABSCESS
Checking Final Appropriateness 
09/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/27/2023
10/03/2023
IV
4.5g
Q6
Abscess
Checking Final Appropriateness 
10/06/2023
CEFTAZIDIME 1GM (VIAL)
10/06/2023
10/12/2023
IVTT
1g
Q8
Thoracic Abscess
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: